9789815274783 - intellectual property rights issues in vaccine development de jain, sachin kumar (3 resultados)
- Tapa blanda
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 79,20
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.
- Tapa blanda
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 76,74
Envío por EUR 5,91Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Editorial: Bentham Science Publishers Singapore Pte. Ltd., 2025
- Tapa blanda
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 82,47
Envío por EUR 43,57Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: new. Paperback. Intellectual Property Rights Issues in Vaccine Development offers a timely exploration of the evolving role of intellectual property (IP) in shaping global vaccine research, innovation, and accessibility. As the world continues to grapple with public health challenges like the COVID-19 pande…mic- this book provides a critical lens on how patents, trade secrets, and international agreements influence vaccine development and distribution. The contents of the book explore the historical evolution of IP in vaccinology, the debate over patent protection, the intersection of legal frameworks and ethical concerns, and the tension between innovation and equitable access. Special attention is given to global case studies, the impact of international agreements, and recommendations for stakeholders across policy, industry, and healthcare sectors. Key features: -Traces the history and legal evolution of vaccine-related IP -Analyzes global access challenges and equity concerns -Explores the role of IP during the COVID-19 pandemic -Examines real-world case studies of vaccine IP dynamics -Offers actionable policy and industry recommendations This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
